BioVie Inc.
BIVI
$7.14
-$0.43-5.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.87M | 9.26M | 8.98M | 8.85M | 8.79M |
| Depreciation & Amortization | 229.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.19M | 23.94M | 25.43M | 32.18M | 38.37M |
| Operating Income | -19.19M | -23.94M | -25.43M | -32.18M | -38.37M |
| Income Before Tax | -18.99M | -24.27M | -25.56M | -32.12M | -36.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.99 | -24.27 | -25.56 | -32.12 | -36.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.99M | -24.27M | -25.56M | -32.12M | -36.29M |
| EBIT | -19.19M | -23.94M | -25.43M | -32.18M | -38.37M |
| EBITDA | -18.96M | -23.71M | -25.20M | -31.95M | -38.14M |
| EPS Basic | -21.14 | -39.62 | -57.08 | -79.24 | -96.28 |
| Normalized Basic EPS | -12.88 | -23.19 | -34.12 | -48.29 | -58.94 |
| EPS Diluted | -21.41 | -39.90 | -57.31 | -79.51 | -96.32 |
| Normalized Diluted EPS | -12.88 | -23.19 | -34.12 | -48.29 | -58.94 |
| Average Basic Shares Outstanding | 4.67M | 3.27M | 2.08M | 1.81M | 1.56M |
| Average Diluted Shares Outstanding | 4.67M | 3.27M | 2.08M | 1.81M | 1.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |